{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:18:00Z","timestamp":1783487880945,"version":"3.55.0"},"reference-count":15,"publisher":"Japan Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1507\/endocrj.ej14-0334","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T23:28:38Z","timestamp":1413329318000},"page":"1141-1144","source":"Crossref","is-referenced-by-count":6,"title":["A newly identified missense mutation in &lt;i&gt;RET&lt;\/i&gt; codon 666 is associated with the development of medullary thyroid carcinoma [Rapid Communication]"],"prefix":"10.1507","volume":"61","author":[{"given":"Masanori","family":"Yamazaki","sequence":"first","affiliation":[{"name":"Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"},{"name":"Department of Drug Discovery Science, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Hanamura","sequence":"additional","affiliation":[{"name":"Division of Breast and Endocrine Surgery, Department of Surgery (II), Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Breast and Endocrine Surgery, Department of Surgery (II), Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Uchino","sequence":"additional","affiliation":[{"name":"Department of Surgery, Noguchi Thyroid Clinic and Hospital Foundation, Beppu 874-0902, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhisa","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ezaki H, Ebihara S, Fujimoto Y, Iida F, Ito K, et al. (1992) Analysis of thyroid carcinoma based on material registered in Japan during 1977-1986 with special reference to predominance of papillary type. <i>Cancer<\/i> 70: 808-814.","DOI":"10.1002\/1097-0142(19920815)70:4<808::AID-CNCR2820700415>3.0.CO;2-L"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Roy M, Chen H, Sippel RS (2013) Current understanding and management of medullary thyroid cancer. <i>Oncologist<\/i> 18: 1093-1100.","DOI":"10.1634\/theoncologist.2013-0053"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. American Thyroid Association Guidelines Task F, Kloos RT, Eng C, Evans DB, Francis GL, et al. (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. <i>Thyroid<\/i> 19: 565-612.","DOI":"10.1089\/thy.2008.0403"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kameyama K, Takami H (2004) Medullary thyroid carcinoma: nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002. <i>Endocr J<\/i> 51: 453-456.","DOI":"10.1507\/endocrj.51.453"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wells SA, Jr., Pacini F, Robinson BG, Santoro M (2013) Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. <i>J Clin Endocrinol Metab<\/i> 98: 3149-3164.","DOI":"10.1210\/jc.2013-1204"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wiench M, Wygoda Z, Gubala E, Wloch J, Lisowska K, et al. (2001) Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.<i> J Clin Oncol<\/i> 19: 1374-1380.","DOI":"10.1200\/JCO.2001.19.5.1374"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Elisei R, Romei C, Cosci B, Agate L, Bottici V, et al. (2007) RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. <i>J Clin Endocrinol Metab<\/i> 92: 4725-4729.","DOI":"10.1210\/jc.2007-1005"},{"key":"8","unstructured":"8. Schuffenecker I, Virally-Monod M, Brohet R, Goldgar D, Conte-Devolx B, et al. (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D&rsquo;etude des Tumeurs a Calcitonine. <i>J Clin Endocrinol Metab<\/i> 83: 487-491."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Uchino S, Noguchi S, Adachi M, Sato M, Yamashita H, et al. (1998) Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas.<i> Jpn J Cancer Res <\/i>89: 411-418.","DOI":"10.1111\/j.1349-7006.1998.tb00579.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Elisei R, Alevizaki M, Conte-Devolx B, Frank-Raue K, Leite V, et al. (2013) 2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer. <i>Eur Thyroid J<\/i> 1: 216-231.","DOI":"10.1159\/000346174"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Muzza M, Cordella D, Bombled J, Bressac-de Paillerets B, Guizzardi F, et al. (2010) Four novel RET germline variants in exons 8 and 11 display an oncogenic potential in vitro.<i> Eur J Endocrinol<\/i> 162: 771-777.","DOI":"10.1530\/EJE-09-0929"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ahmed SA, Snow-Bailey K, Highsmith WE, Sun W, Fenwick RG, et al. (2005) Nine novel germline gene variants in the RET proto-oncogene identified in twelve unrelated cases. <i>J Mol Diagn <\/i>7: 283-288.","DOI":"10.1016\/S1525-1578(10)60556-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Borrello MG, Aiello A, Peissel B, Rizzetti MG, Mondellini P, et al. (2011) Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism. <i>Endocr Relat Cancer<\/i> 18: 519-527.","DOI":"10.1530\/ERC-10-0306"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Romei C, Mariotti S, Fugazzola L, Taccaliti A, Pacini F, et al. (2010) Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. <i>Eur J Endocrinol<\/i> 163: 301-308.","DOI":"10.1530\/EJE-10-0333"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mastroianno S, Torlontano M, Scillitani A, D&rsquo;Aloiso L, Verrienti A, et al. (2011) Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family. <i>Endocrine<\/i> 40: 481-485.","DOI":"10.1007\/s12020-011-9501-2"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/11\/61_EJ14-0334\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:42:10Z","timestamp":1618296130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/11\/61_EJ14-0334\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej14-0334","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}